Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity

Jasmin Barman-Aksoezen, Domenico Girelli, Caterina Aurizi, Xiaoye Schneider-Yin, Natascia Campostrini, Luca Barbieri, Elisabeth I. Minder, Gianfranco Biolcati

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Patients with erythropoietic protoporphyria (EPP) have reduced activity of the enzyme ferrochelatase that catalyzes the insertion of iron into protoporphyrin IX (PPIX) to form heme. As the result of ferrochelatase deficiency, PPIX accumulates and causes severe photosensitivity. Among different patients, the concentration of PPIX varies considerably. In addition to photosensitivity, patients frequently exhibit low serum iron and a microcytic hypochromic anemia. The aims of this study were to (1) search for factors related to PPIX concentration in EPP, and (2) characterize anemia in EPP, i.e., whether it is the result of an absolute iron deficiency or the anemia of chronic disease (ACD). Blood samples from 67 EPP patients (51 Italian and 16 Swiss) and 21 healthy volunteers were analyzed. EPP patients had lower ferritin (p = 0.021) and hepcidin (p = 0.031) concentrations and higher zinc–protoporphyrin (p < 0.0001) and soluble-transferrin-receptor (p = 0.0007) concentrations compared with controls. This indicated that anemia in EPP resulted from an absolute iron deficiency. Among EPP patients, PPIX concentrations correlated with both growth differentiation factor (GDF) 15 (p = 0.012) and male gender (p = 0.015). Among a subgroup of patients who were iron replete, hemoglobin levels were normal, which suggested that iron but not ferrochelatase is the limiting factor in heme synthesis of individuals with EPP.

Original languageEnglish
Pages (from-to)433-441
JournalJournal of Inherited Metabolic Disease
Volume40
Issue number3
DOIs
Publication statusPublished - May 2017

Fingerprint

Erythropoietic Protoporphyria
Iron
Ferrochelatase
Heme
Anemia
Growth Differentiation Factor 15
Hepcidins
Transferrin Receptors
Iron-Deficiency Anemias
Ferritins
Healthy Volunteers
Hemoglobins
Chronic Disease

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity. / Barman-Aksoezen, Jasmin; Girelli, Domenico; Aurizi, Caterina; Schneider-Yin, Xiaoye; Campostrini, Natascia; Barbieri, Luca; Minder, Elisabeth I.; Biolcati, Gianfranco.

In: Journal of Inherited Metabolic Disease, Vol. 40, No. 3, 05.2017, p. 433-441.

Research output: Contribution to journalArticle

Barman-Aksoezen, Jasmin ; Girelli, Domenico ; Aurizi, Caterina ; Schneider-Yin, Xiaoye ; Campostrini, Natascia ; Barbieri, Luca ; Minder, Elisabeth I. ; Biolcati, Gianfranco. / Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity. In: Journal of Inherited Metabolic Disease. 2017 ; Vol. 40, No. 3. pp. 433-441.
@article{417cd9a4631e45cf89aec79afc4d7261,
title = "Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity",
abstract = "Patients with erythropoietic protoporphyria (EPP) have reduced activity of the enzyme ferrochelatase that catalyzes the insertion of iron into protoporphyrin IX (PPIX) to form heme. As the result of ferrochelatase deficiency, PPIX accumulates and causes severe photosensitivity. Among different patients, the concentration of PPIX varies considerably. In addition to photosensitivity, patients frequently exhibit low serum iron and a microcytic hypochromic anemia. The aims of this study were to (1) search for factors related to PPIX concentration in EPP, and (2) characterize anemia in EPP, i.e., whether it is the result of an absolute iron deficiency or the anemia of chronic disease (ACD). Blood samples from 67 EPP patients (51 Italian and 16 Swiss) and 21 healthy volunteers were analyzed. EPP patients had lower ferritin (p = 0.021) and hepcidin (p = 0.031) concentrations and higher zinc–protoporphyrin (p < 0.0001) and soluble-transferrin-receptor (p = 0.0007) concentrations compared with controls. This indicated that anemia in EPP resulted from an absolute iron deficiency. Among EPP patients, PPIX concentrations correlated with both growth differentiation factor (GDF) 15 (p = 0.012) and male gender (p = 0.015). Among a subgroup of patients who were iron replete, hemoglobin levels were normal, which suggested that iron but not ferrochelatase is the limiting factor in heme synthesis of individuals with EPP.",
author = "Jasmin Barman-Aksoezen and Domenico Girelli and Caterina Aurizi and Xiaoye Schneider-Yin and Natascia Campostrini and Luca Barbieri and Minder, {Elisabeth I.} and Gianfranco Biolcati",
year = "2017",
month = "5",
doi = "10.1007/s10545-017-0017-7",
language = "English",
volume = "40",
pages = "433--441",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity

AU - Barman-Aksoezen, Jasmin

AU - Girelli, Domenico

AU - Aurizi, Caterina

AU - Schneider-Yin, Xiaoye

AU - Campostrini, Natascia

AU - Barbieri, Luca

AU - Minder, Elisabeth I.

AU - Biolcati, Gianfranco

PY - 2017/5

Y1 - 2017/5

N2 - Patients with erythropoietic protoporphyria (EPP) have reduced activity of the enzyme ferrochelatase that catalyzes the insertion of iron into protoporphyrin IX (PPIX) to form heme. As the result of ferrochelatase deficiency, PPIX accumulates and causes severe photosensitivity. Among different patients, the concentration of PPIX varies considerably. In addition to photosensitivity, patients frequently exhibit low serum iron and a microcytic hypochromic anemia. The aims of this study were to (1) search for factors related to PPIX concentration in EPP, and (2) characterize anemia in EPP, i.e., whether it is the result of an absolute iron deficiency or the anemia of chronic disease (ACD). Blood samples from 67 EPP patients (51 Italian and 16 Swiss) and 21 healthy volunteers were analyzed. EPP patients had lower ferritin (p = 0.021) and hepcidin (p = 0.031) concentrations and higher zinc–protoporphyrin (p < 0.0001) and soluble-transferrin-receptor (p = 0.0007) concentrations compared with controls. This indicated that anemia in EPP resulted from an absolute iron deficiency. Among EPP patients, PPIX concentrations correlated with both growth differentiation factor (GDF) 15 (p = 0.012) and male gender (p = 0.015). Among a subgroup of patients who were iron replete, hemoglobin levels were normal, which suggested that iron but not ferrochelatase is the limiting factor in heme synthesis of individuals with EPP.

AB - Patients with erythropoietic protoporphyria (EPP) have reduced activity of the enzyme ferrochelatase that catalyzes the insertion of iron into protoporphyrin IX (PPIX) to form heme. As the result of ferrochelatase deficiency, PPIX accumulates and causes severe photosensitivity. Among different patients, the concentration of PPIX varies considerably. In addition to photosensitivity, patients frequently exhibit low serum iron and a microcytic hypochromic anemia. The aims of this study were to (1) search for factors related to PPIX concentration in EPP, and (2) characterize anemia in EPP, i.e., whether it is the result of an absolute iron deficiency or the anemia of chronic disease (ACD). Blood samples from 67 EPP patients (51 Italian and 16 Swiss) and 21 healthy volunteers were analyzed. EPP patients had lower ferritin (p = 0.021) and hepcidin (p = 0.031) concentrations and higher zinc–protoporphyrin (p < 0.0001) and soluble-transferrin-receptor (p = 0.0007) concentrations compared with controls. This indicated that anemia in EPP resulted from an absolute iron deficiency. Among EPP patients, PPIX concentrations correlated with both growth differentiation factor (GDF) 15 (p = 0.012) and male gender (p = 0.015). Among a subgroup of patients who were iron replete, hemoglobin levels were normal, which suggested that iron but not ferrochelatase is the limiting factor in heme synthesis of individuals with EPP.

UR - http://www.scopus.com/inward/record.url?scp=85011829513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011829513&partnerID=8YFLogxK

U2 - 10.1007/s10545-017-0017-7

DO - 10.1007/s10545-017-0017-7

M3 - Article

C2 - 28185024

AN - SCOPUS:85011829513

VL - 40

SP - 433

EP - 441

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 3

ER -